» » »

Cancer-Causing Proteins Cary NC

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

William R Berr, MR
(919) 852-1994
218 Ashville Ave Ste 20
Cary, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Sunil J Desai, MD
(919) 233-0059
300 Keisler Dr Ste 204
Cary, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Municipal Med Coll, Gujarat Univ, Ahmedabad, Gujarat, India
Graduation Year: 1983

Data Provided by:
Mark L Graham II, MD
(919) 966-4431
Cary, NC
Specialties
Internal Medicine, Medical Oncology
Gender
Male
Education
Medical School: Mayo Med Sch, Rochester Mn 55905
Graduation Year: 1982
Hospital
Hospital: University Of North Carolina H, Chapel Hill, Nc
Group Practice: Cary Oncology

Data Provided by:
Mark L Graham
(919) 233-8585
300 Ashville Ave
Cary, NC
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
A Bartlett Pandite, MD
Cary, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Of Liverpool, Fac Of Med, Liverpool, Uk (352-06 Prior 1/71)
Graduation Year: 1983

Data Provided by:
Cassandra N Moore
(919) 854-6900
216 Ashville Ave
Cary, NC
Specialty
Hematology / Oncology

Data Provided by:
Mark L Graham, MD
(919) 233-8585
300 Ashville Ave Ste 180
Cary, NC
Specialties
Internal Medicine, Medical Oncology
Gender
Male
Education
Medical School: Mayo Med Sch, Rochester Mn 55905
Graduation Year: 1982

Data Provided by:
Andrew Scott Kennedy, MD
(919) 854-4588
300 Ashville Ave Ste 110
Cary, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Loma Linda Univ Sch Of Med, Loma Linda Ca 92350
Graduation Year: 1991

Data Provided by:
Scott Lee Sailer, MD
(919) 854-4588
300 Ashville Ave Ste 110
Cary, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Harvard Med Sch, Boston Ma 02115
Graduation Year: 1984

Data Provided by:
Kim M Boerick, MD
1001 Winstead Dr Ste 200
Cary, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Data Provided by:

Cancer-Causing Proteins

Provided By:

Scientists are closer to understanding how a recently approved class of antibiotics may work against cancer.

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

The researchers also found that thiazoles may inhibit proteasomes, a molecular complex within cells that disposes of old proteins marked for destruction. Recently, a number of proteasome inhibitors have shown promise against cancer. One of these inhibitors, bortezomib (Velcade), has proven effective against a number of cancers, including myeloma and certain forms of lymphoma.

The new research, which appears in the online journal PLoS ONE, points to the possible anti-cancer use of thiazoles in the future. In a university news release, study author Andrei Gartel, an associate professor of molecular genetics, said that by using thiazole antibiotics in combination with well-known proteasome inhibitors, "we may see a synergy that allows us to markedly reduce the dose of any one of these drugs and still effectively kill the cancer cells."

More information

Read more about cancer treatments at the U.S. National Cancer Institute.

SOURCE: University of Illinois at Chicago, news release, Aug. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com